No Data
AIDIGONG (00286.HK) received the resumption guidance from the Stock Exchange.
On March 13, the company AIDIGONG (00286.HK) announced that on March 12, 2025, it received a letter from the stock exchange, which listed the guidelines for the resumption of trading of the company's shares as follows: (a) conduct an independent forensic investigation into the matters (including) and other related allegations, assess the impact on the company's Business Operation and financial status, publish the investigation results and take appropriate remedial measures; (b) demonstrate that there are no reasonable regulatory concerns regarding the integrity, capability, and/or character of any persons who have a significant impact on the group's management and/or the management and operation of the company, concerns that may affect investors.
AIDIGONG (00286) is obtaining legal opinions from its legal advisors in mainland China regarding arbitration matters.
AIDIGONG (00286) announced that on February 10, 2025, the company received news regarding Zhu Yufei related to Guangdong Wanjia...
Express News | Aidigong Maternal & Child Health Ltd - Pending Results of Arbitration RMB7.27 Mln of Equity in Shenzhen Aidigong to Be Placed Under Temporary Asset Preservation
Express News | Aidigong Maternal & Child Health - Individual Sought to Resolve Disagreement With Guangdong Wanjia on Exercise of Shareholders Rights
Aidigong Maternal & Child Health Trading Halt Announced
Express News | Aidigong Maternal & Child Health - Trading Halted From 21 Feb Pending Release of Announcement
Market Cool On Aidigong Maternal & Child Health Limited's (HKG:286) Revenues Pushing Shares 28% Lower
